Talaj/iStock via Getty Images
Following a ~38% sell-off in the previous session, CareDx (NASDAQ:CDNA) traded higher on Friday after the company said it doesn’t expect the use of its testing products to change in response to the newly released draft Local Coverage Determination (LCD) related